[Advances in antiretroviral therapy].
In spite of all the efforts that has been made in prevention and the success of  antiretroviral therapy (ART), AIDS remains a serious public health problem. So,  there is a need for development of new antiretrovirals (ARVs) and new therapeutic  strategies. New ARVs are currently on advanced stages of clinical evaluation.  New therapeutic strategies intend to evaluate the toxicity risk, drug resistance,  drug-drug interactions, costs and adherence. Coformulations of fixed-dose drug  combination are important advantages of ART that improve adherence, quality of  life, evolving to better therapeutic results and reduction of health resources.
Serviço de Doenças Infecciosas, Faculdade de Medicina de Lisboa/Hospital de Santa Maria (Centro Hospitalar Lisboa Norte, EPE), Lisboa, Portugal.
Francisco
F
Antunes
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans
D044966:Anti-Retroviral Agents